Publicacións en colaboración con investigadores/as de University of Turku (57)

2024

  1. Genome-wide Association Study of Susceptibility to Respiratory Syncytial Virus Hospitalization in Young Children <5 Years of age

    Journal of Infectious Diseases, Vol. 230, Núm. 2, pp. e333-e341

  2. The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus

    Nature communications, Vol. 15, Núm. 1, pp. 3083

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  3. Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe

    Vaccine, Vol. 41, Núm. 16, pp. 2707-2715

  4. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

  5. Identification of Proteomic Biomarkers in Proliferative Verrucous Leukoplakia through Liquid Chromatography With Tandem Mass Spectrometry

    Laboratory investigation; a journal of technical methods and pathology, Vol. 103, Núm. 10, pp. 100222

  6. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

    The Lancet Infectious Diseases, Vol. 23, Núm. 7, pp. 856-866

  7. Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European men

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 3, pp. 1520-1532

  8. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 4, pp. 341-353

2022

  1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

    The Lancet, Vol. 399, Núm. 10340, pp. 2047-2064

  2. Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials

    Journal of Clinical Epidemiology, Vol. 147, pp. 11-20

2021

  1. AMP-activated protein kinase (AMPK) signaling in GnRH neurons links energy status and reproduction

    Metabolism: Clinical and Experimental, Vol. 115

  2. Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 6, pp. 1818-1831

  3. Self-Reported Shorter Than Desired Ejaculation Latency and Related Distress—Prevalence and Clinical Correlates: Results From the European Male Ageing Study

    Journal of Sexual Medicine, Vol. 18, Núm. 5, pp. 908-919

  4. Small extracellular vesicle-mediated targeting of hypothalamic AMPKα1 corrects obesity through BAT activation

    Nature Metabolism, Vol. 3, Núm. 10, pp. 1415-1431

2020

  1. Association between DNA methylation and ADHD symptoms from birth to school age: a prospective meta-analysis

    Translational Psychiatry, Vol. 10, Núm. 1

  2. Central Ceramide Signaling Mediates Obesity-Induced Precocious Puberty

    Cell Metabolism, Vol. 32, Núm. 6, pp. 951-966.e8

  3. Repositioning of the global epicentre of non-optimal cholesterol

    Nature, Vol. 582, Núm. 7810, pp. 73-77

2019

  1. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)

    Nature Communications